• zlatiah@lemmy.world
    link
    fedilink
    English
    arrow-up
    22
    ·
    edit-2
    4 days ago

    Important additional context on this… TLDR is that the post is only a “feel-good” post and misrepresented reality; real life is a lot more nuanced and fucked up

    Mary E Brunkow solely worked in industry (a.k.a. the scientific slang for working in something like a pharmaceuticals cpmpany) after her PhD, instead of in academia like most Nobel Prize laureates. Industry researchers rarely publish. And 34 published papers may seem low by Nobel standards but is a lot. I don’t think I personally know any industry researchers that are this prolific; some full professors even don’t have this many papers

    The bigger takeaway from this story is not “anyone can make it” if they have a good idea… Brunkow was extremely prolific as a researcher. A better takeaway may be instead of focusing on an individual solution, systematically why academia has such an excessive focus on publication metrics; people are trying to move away from it which is good. Another thing: her old company (Celltech) went defunct in 2004 and Brunkow was allegedly laid off (and no one at the time realized the importance of her discovery) which is probably a better take home message

    Her Wikipedia page as reference: https://en.wikipedia.org/wiki/Mary_E._Brunkow.

    Also some discussion about this on r/labrats if anyone wants to go over to the forbidden site: https://reddit.com/r/labrats/comments/1o1pgo1/mary_e_brunkow_one_of_this_years_nobel_prize

    • TempermentalAnomaly@lemmy.world
      link
      fedilink
      English
      arrow-up
      4
      ·
      4 days ago

      Also some discussion about this on r/labrats if anyone wants to go over to the forbidden site:

      I went. It was a mistake. Most comments were about how this post was written by ChatGPT followby how they’d love to have 34 publications. There were a couple taking about what you wrote, but I think your comment captures the best of it.

  • Vex_Detrause@lemmy.ca
    link
    fedilink
    English
    arrow-up
    12
    ·
    edit-2
    4 days ago

    No one was mentioning what Mary Elizabeth Brunkow did. Mary Elizabeth Brunkow (born 1961) is an American molecular biologist and immunologist. She is known for co-identifying the gene later named FOXP3 as the cause of the scurfy mouse phenotype, a finding that became foundational for modern regulatory T cell biology.

  • SoftestSapphic@lemmy.world
    link
    fedilink
    English
    arrow-up
    17
    ·
    5 days ago

    *But also do it in your free time after your real job and do it for free

    It really is amazing any non-corporate research ever gets this far.

  • tetris11@lemmy.ml
    link
    fedilink
    English
    arrow-up
    19
    ·
    5 days ago

    I have a high school friend who owns a paper mill. He was a rich kid who never did the work, and always took credit for others work.

    He has an h-index of 90 and 200,000 citations. He is not a professor.

    • errer@lemmy.world
      link
      fedilink
      English
      arrow-up
      5
      ·
      5 days ago

      I am not following…how does he have so many papers with a high number of citations if he is not a professor? Just an extremely prolific postdoc/person on soft money?

  • HexesofVexes@lemmy.world
    link
    fedilink
    English
    arrow-up
    6
    ·
    4 days ago

    The three pathways for most academics

    Option 1 - shit out a large pile of bad (either misleading, over-sensationalised, or just clearly partial work) papers, but get funding to do the same for another year.

    Option 2 - work hard to create a quality paper, run out of time, no more funding, off you go to industry.

    Option 3 - take a teaching intensive role and never have any time for research, oh and also get paid less than in industry.

  • Maudelix@lemmy.world
    link
    fedilink
    English
    arrow-up
    4
    ·
    5 days ago

    I will be forever grateful that my PI for my doctorate focused on technical and scientific hands-on skills rather than sitting at a desk and writing papers. It helped me much more in my current industry, especially in the field of small-scale bioreactor work.